Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency

Tundra lists 1 Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07113964

QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)

This study will evaluate the safety and efficacy of QL1706 and Olaparib in human epidermal growth factor receptor 2 (HER2)-negative unresectable and/or metastatic breast cancer who had received 2-4 line of prior systematic therapy.

Gender: FEMALE

Ages: 18 Years - 75 Years

Updated: 2025-08-11

1 state

Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency